Holen Sie sich die Stockscreener-App
1.28
0.78%
-0.01
Handel nachbörslich:
1.26
-0.02
-1.56%
Schlusskurs vom Vortag:
$1.29
Offen:
$1.3
24-Stunden-Volumen:
37,202
Relative Volume:
0.12
Marktkapitalisierung:
$7.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.91M
KGV:
-0.3926
EPS:
-3.26
Netto-Cashflow:
$-6.14M
1W Leistung:
-7.25%
1M Leistung:
-21.47%
6M Leistung:
-33.68%
1J Leistung:
-54.45%
1-Tages-Spanne:
$1.25
$1.31
1-Wochen-Bereich:
$1.24
$1.36
52-Wochen-Spanne:
$1.15
$23.80
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Firmenname
Galmed Pharmaceuticals Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GLMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.28 | 6.96M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-05-22 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | Eingeleitet | Craig Hallum | Buy |
| 2020-01-30 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-12-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Buy |
| 2018-08-02 | Bestätigt | Maxim Group | Buy |
| 2018-07-13 | Eingeleitet | Stifel | Buy |
| 2018-07-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-06-12 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-15 | Hochstufung | Maxim Group | Hold → Buy |
| 2018-02-14 | Herabstufung | Maxim Group | Buy → Hold |
| 2018-02-12 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Eingeleitet | ROTH Capital | Buy |
| 2017-08-08 | Bestätigt | H.C. Wainwright | Buy |
| 2017-07-31 | Bestätigt | Maxim Group | Buy |
| 2016-08-01 | Bestätigt | Maxim Group | Buy |
| 2016-07-06 | Fortgesetzt | ROTH Capital | Buy |
| 2016-03-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-05-06 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Galmed Pharmaceuticals Ltd Aktie (GLMD) Neueste Nachrichten
How to read the order book for Galmed Pharmaceuticals Ltd.Market Growth Summary & Stock Portfolio Risk Management - Newser
What indicators show strength in Galmed Pharmaceuticals Ltd.2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser
Is Galmed Pharmaceuticals Ltd. stock poised for growthMarket Volume Report & Growth Focused Investment Plans - Newser
Can a trend reversal in Galmed Pharmaceuticals Ltd. lead to recoveryWeekly Investment Report & Technical Confirmation Alerts - Newser
Ranking Galmed Pharmaceuticals Ltd. among high performing stocks via toolsMarket Trend Report & Reliable Intraday Trade Plans - Newser
Pattern recognition hints at Galmed Pharmaceuticals Ltd. upsideQuarterly Trade Review & High Win Rate Trade Tips - Newser
Is Galmed Pharmaceuticals Ltd. stock ready for a breakoutJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - Newser
Trend analysis for Galmed Pharmaceuticals Ltd. this weekStock Surge & Verified Short-Term Plans - Newser
Tools to monitor Galmed Pharmaceuticals Ltd. recovery probabilityJuly 2025 Drop Watch & Daily Stock Trend Reports - Newser
Quantitative breakdown of Galmed Pharmaceuticals Ltd. recent move2025 Institutional Moves & Weekly Top Performers Watchlists - Newser
How to escape a deep drawdown in Galmed Pharmaceuticals Ltd.Quarterly Trade Report & Precise Trade Entry Recommendations - Newser
What’s next for Galmed Pharmaceuticals Ltd. stock priceJuly 2025 Fed Impact & Consistent Profit Trading Strategies - Newser
Can Galmed Pharmaceuticals Ltd. lead its sector in growthTrade Exit Summary & High Conviction Buy Zone Picks - khodrobank.com
Can Galmed Pharmaceuticals Ltd. ride the EV wavePrice Action & Consistent Profit Focused Trading Strategies - khodrobank.com
Does Galmed Pharmaceuticals Ltd. have strong fundamentalsQuarterly Portfolio Report & Free Fast Gain Swing Trade Alerts - khodrobank.com
Applying sector rotation models to Galmed Pharmaceuticals Ltd.July 2025 Setups & Entry and Exit Point Strategies - Newser
What’s the outlook for Galmed Pharmaceuticals Ltd.’s sectorGDP Growth & Real-Time Sentiment Analysis - khodrobank.com
Is this a good reentry point in Galmed Pharmaceuticals Ltd.Weekly Trade Summary & Community Consensus Picks - Newser
Does Galmed Pharmaceuticals Ltd. have a sustainable dividendEarnings Beat & Technical Confirmation Alerts - khodrobank.com
Momentum divergence signals in Galmed Pharmaceuticals Ltd. chart2025 Technical Overview & Reliable Breakout Forecasts - Newser
Can Galmed Pharmaceuticals Ltd. grow without dilution2025 Major Catalysts & Smart Investment Allocation Tips - khodrobank.com
Is Galmed Pharmaceuticals Ltd. stock overvalued or fairly priced2025 Geopolitical Influence & High Return Trade Opportunity Guides - khodrobank.com
Key resistance and support levels for Galmed Pharmaceuticals Ltd.Weekly Gains Report & Stepwise Entry/Exit Trade Alerts - Newser
Is Galmed Pharmaceuticals Ltd. a defensive stockDay Trade & Reliable Price Action Trade Plans - khodrobank.com
How to build a dashboard for Galmed Pharmaceuticals Ltd. stock2025 Market WrapUp & AI Based Buy and Sell Signals - Newser
Should value investors consider Galmed Pharmaceuticals Ltd.2025 EndofYear Setup & Growth Focused Investment Plans - خودرو بانک
Short Term Trend Reversal in Galmed Pharmaceuticals Ltd. PossibleBreakout Watch & Weekly Watchlist for Consistent Profits - beatles.ru
Is it time to cut losses on Galmed Pharmaceuticals Ltd.Inflation Watch & Verified Technical Signals - Newser
How to manage a losing position in Galmed Pharmaceuticals Ltd.Portfolio Update Summary & Advanced Swing Trade Entry Plans - Newser
What earnings revisions data tells us about Galmed Pharmaceuticals Ltd.Market Risk Report & Free Reliable Trade Execution Plans - Newser
Will Galmed Pharmaceuticals Ltd. price bounce be sustainableGap Up & Stepwise Entry and Exit Trade Signals - Newser
Earnings Chart Overlay Points to Galmed Pharmaceuticals Ltd. Upside getLinesFromResByArray error: size == 0 - 더경남뉴스
Sentiment analysis tools applied to Galmed Pharmaceuticals Ltd.2025 Top Gainers & High Win Rate Trade Tips - Newser
Is Galmed Pharmaceuticals Ltd. meeting your algorithmic filter criteriaJuly 2025 Macro Moves & Safe Entry Momentum Tips - Newser
How moving averages guide Galmed Pharmaceuticals Ltd. tradingMarket Trend Report & AI Enhanced Trading Signals - Newser
Finanzdaten der Galmed Pharmaceuticals Ltd-Aktie (GLMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):